SCHEMBL23716382

SCHEMBL23716382

C/C(Cl)=C\C=C(/N)Cc1ccc(C#N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.42
CYP2A6 P11509 1/20 0.42
IDO1 P14902 2/20 0.41
NOS3 P29474 2/20 0.41
NOS1 P29475 2/20 0.41
CTBP2 P56545 1/20 0.39
MAPK8 P45983 1/20 0.37
CYP19A1 P11511 2/20 0.36
CYP11B1 P15538 4/20 0.35
CYP11B2 P19099 4/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
IDH1 O75874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23716379 0.80 IDO1 (0.38) CYP2A6IDO1CTBP2MAPK8NPC1
SCHEMBL23716034 0.80 IDO1 (0.38) IDO1CTBP2NPC1RAB9ASMN1; SMN2
SCHEMBL23715862 0.73 IDO1 (0.41) IDO1KMT2ATSHR
SCHEMBL23716227 0.72 GABRA1 (0.40) IDO1NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL6616686 0.72 CYP2A6 (0.58) LOXL2CYP2A6IDO1NOS3NOS1
SCHEMBL23715869 0.71 SMN1; SMN2 (0.33) IDO1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL23716112 0.71 PIK3CA (0.43) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL23716287 0.70 ANO1 (0.34)
SCHEMBL2701963 0.69 IDO1 (0.61) LOXL2CYP2A6IDO1NOS3NOS1
SCHEMBL4703302 0.69 CA2 (0.57) LOXL2CYP2A6IDO1CTBP2MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 EP disclosed